AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald

The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…

Click here to view the original article.